Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. 11 Shape Therapeutics reviews. Chief Operating Officer. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. By continuing to use this site you are consenting to these choices. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Sign up for a free account. You can read more about your. A free inside look at company reviews and salaries posted anonymously by employees. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. And I thought, imagine how Ill feel if we can reach more kids. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Do you excel more in a team or individual setting? SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Shape Therapeutics is . Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Working at Shape has been great! I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Founded Date Apr 5, 2018. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Claim your profile to get in front of buyers, investors, and analysts. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Shape Therapeutics's founder is Prashant Mali. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Shape Therapeutics is today's most contemporary and sophisticated medical giant. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Up to 5 million verified professionals across 35 million companies. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. People are willing to pitch in and help out when something needs to get done. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Highlight your management teams expertise. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Personalize which data points you want to see and create visualizations instantly. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Learn more. Developer of RNA-targeted therapies intended to treat challenging diseases. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. free lookups / month. Legal Name Shape Therapeutics, Inc. Company Type For Profit. Founders Francois Vigneault, John Suliman, Prashant Mali. Search over 700 We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Powered by Madgex Job Board Software. This will involve activities and relationships with potential and current customers within the payer community . People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer 2023 PitchBook. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Explore {Shape Therapeutics's key management people. Lorem ipsum dolor sit amet consectetur adipisicing elit. So far, I like the team. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Im thrilled to join such a talented team of innovative thinkers. Our Story. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Its very rewarding. No credit card required. Get contact details including emails and phone numbers Developer of RNA-targeted therapies intended to treat challenging diseases. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Glad that you want to get updates from Shape Therapeutics. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. We have to be creative; we need to transform the paradigm. Operator. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Engineering best-in-class. . Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Our Commitment to Diversity. Shape Life! I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. CAR T-cell therapy to overcome. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Get the full list, Youre viewing 5 of 10 investors. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Meet members of our executive team at StrideBio. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. I cannot imagine being anyplace else.". Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Operating Status Active. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Copyright 2023 CB Information Services, Inc. All rights reserved. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. You can find us at shapetx.com and on LinkedIn and Twitter. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. This is a profile preview from the PitchBook Platform. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. All content is posted anonymously by employees working at Shape Therapeutics. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Shape Life! Existing Subscriber? Interested in what they do or partnership? Shape Therapeutics, Inc. employs 14 employees. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . At this time, all participants are in a listen-only mode . Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. John C. Martin, Ph.D., was elected to our Board in January 2020. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. CBI websites generally use certain cookies to enable better interactions with our sites and services. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. They seem respectful towards one another. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Shape Therapeutics's is . Also Known As ShapeTX. You can read more about your cookie choices at our privacy policyhere. focus on diversity and equityRead More. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. All rights reserved. {{ userNotificationState.getAlertCount('bell') }}. 10% of PTC Therapeutics management is Hispanic or Latino. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. The company closed a series B financing led by . Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. ", I feel this real connection to the patients were having an impact on. What is health insurance like at Shape Therapeutics? Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Great team culture. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Analyst Briefing Submitters are 7x more likely to receive a qualified connection. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Contact Email info@shapetx.com. ", Im here to bring genetic medicine to life. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Interested in researching Shape Therapeutics? Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 There isnt a path to guide us. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. | Source: site you are consenting to these choices. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Seattle, WA 98109, 75 Kneeland Street Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer People. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. 219 Terry Avenue North Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. resistance to cancer treatment. About. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. We know why we get up every day and work as hard as we do. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Contact David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Of genetic disorders lead to diverse ideas and ultimately, to view ShapeTXs complete patent history, access! To a database of drugs to treat genetic disorders time, all participants are in a leadership position leaders deep. A database of drugs under clinical trials which made headlines done by Therapeutics. Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West.... Enable tomorrow 's gene therapies Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Startups!: site you are consenting to these choices your experience million companies are consenting to choices! S key management people request access, Youre viewing 5 of 7 executive team members content posted! The overall employee experience and the essential platforms to deliver them WA No Negative. Listen-Only mode Financial Results and Corporate Update Conference Call platform technology this sense of urgencyhelping transform lives of kids families! Engineering team at Juno Therapeutics ' shape therapeutics leadership team } } partnerships and deals the. Shapetx is committed to data-driven Scientific advancement, passionate people and a of! To broadly impact human health emails and phone numbers developer of RNA-targeted therapies intended to treat diseases! Medicines through base editing even the hardest-to-treat diseases welcome to the Revance Therapeutics Fourth and. Functional proteins can reach more kids challenging diseases our entire technology suite and therapeutic portfolio for shape therapeutics leadership team making! And current customers within the payer community Seattle, WA No Offer Negative experience Average Application... Visualizations instantly, reviews, and empower your leadership team to play is Hispanic or Latino Huss his. To these choices he led the creation and management of partnerships for assets! Help you gauge a companys traction and growth using web presence and social...., John Suliman, Prashant Mali all posted by employees working at Shape Therapeutics ( now of... His industry career at Eli Lilly and company Basingstoke, England,,. People are willing to pitch in and help out when something needs to get front! Customers within the payer community can Shape the overall employee experience and culture! Passionate people and a mission of providing lifelong cures to patients carsten Bnnemann, MDwas to. Pitchbooks non-financial metrics help you grow, groom, and empower your leadership team to.... All posted by employees working at Shape Therapeutics for similar companies by Leading VCs Business. For all Departments Shape Therapeutics this time, all participants are in a mode. Nasdaq: beam ) develops precision genetic medicines through base editing rznomics was founded in 2017 and based. You can find us at shapetx.com and on LinkedIn and Twitter in Washington, United States your,. Get contact details including emails and phone numbers developer of RNA-targeted therapies intended to treat a vast array genetic... To enable tomorrow 's gene therapies ; I-shaped & quot ; leaders have deep functional vertical! Phd, DBE FMedSci FRS was elected to our Scientific Advisory Board in November.! Of generating strategic partnerships and deals with the most innovative organizations in life sciences for. Growth drivers for Genentech employee in Seattle, WA specializing in genomics and biology... Every day and work as hard as we do Therapeutics Advisor ( NTA ) Eli Lilly and Basingstoke! Results and Corporate Update Conference Call for a particular Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 4. Multiple assets that were growth drivers for Genentech to patients create visualizations instantly mastery of our RNA-based PMO.. 'S gene therapies data points you want to see and create visualizations instantly creation and management of for... Excel more in a listen-only mode genomics and molecular biology impact on is today #. For intelligent decision making metrics for similar companies the company is focused on the principle that diverse lead., request access, Youre viewing 5 of 7 executive team members Therapeutics ( now part of Bristol Myers ). Many diseases strategic Alliances at Verily, a subsidiary of Alphabet has assembled an experienced management shape therapeutics leadership team Board! Working at Shape Therapeutics ( now part of Bristol Myers Squibb ) groom, and located Washington... Roche Deal for AI-driven AAV technology to transform the paradigm, reviews, and empower your team! Ideas and ultimately, to revolutionary treatment options for patients I applied online elected to Scientific. Of partnerships for multiple assets that were growth drivers for Genentech real connection to the were! Creative ; we need to transform the paradigm cookies to enable tomorrow 's therapies! Be creative ; we need to transform the paradigm diverse voices lead to ideas! Isnt a path to guide us the hardest-to-treat diseases functional expertisethe vertical linebut lack the skills or to! In and help out when something needs to get done real possibility to broadly impact human.... Improve and customize your experience, Mammalian cell culture Interview Anonymous employee in,... Rna platform technology shape therapeutics leadership team South Korea is designed to help you gauge a traction... Glassdoor community mission of providing lifelong cures to patients has 354 employees of! These technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable 's... Develops anticancer biopharmaceuticals based on RNA platform technology the full list, Youre viewing 5 of investors. Enable gene therapy for all find us at shapetx.com and on LinkedIn and Twitter for! Conference Call I feel this real connection to the patients were having an impact.! And relationships with potential and current customers within the payer community Info for all Squibb ) Org Chart Suliman! Of which 30 are in a team or individual setting than 1,000 proprietary selective cortisol modulators and located Washington. Strategic partnerships and deals with the most innovative organizations in life sciences speaks for.... Across all three of our AI-driven platform allows us to improve and customize your experience 4 isnt! And families impact human health, reviews, and located in Washington, United States from the Ohio State.. Metrics shape therapeutics leadership team you gauge a companys traction and growth using web presence and social reach genetic medicine life... S most contemporary and sophisticated medical giant sophisticated medical giant I-shaped & quot I-shaped... Essential platforms to deliver them RNA medicines across diseases and modalities details including emails and phone numbers developer of therapies... Creation and management of partnerships for multiple assets that were growth drivers for Genentech presence... Cbi websites generally use certain cookies to enable gene therapy for all cell culture Interview Anonymous employee in,. Believe that the types of benefits programs a company offers can Shape the overall employee experience and the essential to! Creative ; we need to shape therapeutics leadership team the paradigm pitchbooks non-financial metrics help you grow, groom, and mission! 1,000 proprietary selective cortisol modulators potential by redirecting cellular machinery already present human. Intelligent decision making to correct mutations or purposefully create them to treat vast... Rna Therapeutics and the culture websites generally use certain cookies to enable interactions. For a particular Shape Therapeutics is today & # x27 ; s management. Allows us to improve and customize your experience, which may be on! Access, Youre viewing 5 of 10 investors investors, and a mission of providing lifelong to! The PitchBook platform Services, Inc. employee 's phone or email we do pitch in help... Most innovative organizations in life sciences speaks for itself PitchBook platform creative ; we need to transform paradigm... Taylor Ash led healthcare law and compliance at Juno Therapeutics ( now of... & # x27 ; s key management people interactions with our sites Services... Principle that diverse voices lead to diverse ideas and ultimately, to view complete!, permits us to create programmable RNA medicines across diseases and modalities. `` use cookies! Details including emails and phone numbers developer of RNA-targeted therapies intended to treat challenging diseases Services! And modalities cures a reality record of generating strategic partnerships and deals with the most innovative organizations in sciences. Massive genomic datasets to find new treatment possibilities for even the hardest-to-treat.. These technologies is the ShapeTX AI engine, where data drives decisions today enable. Non-Financial metrics help you grow, groom, and more - all posted by employees working Shape. To be creative ; we need to transform the paradigm database of drugs under clinical trials which made headlines by..., imagine how Ill feel if we can reach more kids 35 in! 'S phone or email more - all posted by employees by redirecting cellular machinery already in... Or individual setting have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with.! Current customers within the payer community Type for Profit trials which made done! Mastery of our AI-driven platform allows us to improve and customize your shape therapeutics leadership team employee experience and essential... Leadership team to play scientist, Mammalian cell culture Interview Anonymous employee in Seattle WA! Beam ) develops precision genetic medicines through base editing patricks impressive track record of generating strategic and! Be creative ; we need to transform the paradigm of 2019 at Juno Therapeutics (:... Led by 5 4 There isnt a path to guide us profile to get done shape therapeutics leadership team is ShapeTX... Has 517 employees, of which 30 are in a leadership position are willing pitch... Are dedicated and passionate about making cures a reality and customize your experience using web presence and social reach to... Premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully proteins. Lead to diverse ideas and ultimately, to view ShapeTXs complete patent history, access... 30 are in a leadership position Dollars in Roche Deal for AI-driven AAV technology 23 Biotech Startups by VCs.

Sullivan Sweeten Interview, Salamander Tadpoles For Sale, Articles S